ADVERTISEMENT

Pharma Sector Check - Covid-19 Vaccine Opportunity - Will It Sustain? Nirmal Bang Insight

Pharma Sector Check - Covid-19 Vaccine Opportunity - Will It Sustain? Nirmal Bang Insight

<div class="paragraphs"><p>An employee removes vials of Covishield, the local name for the Covid-19 vaccine developed by AstraZeneca Plc&nbsp;at the Serum Institute of India Ltd.&nbsp;in Pune, Maharashtra, India. (Photographer: Dhiraj&nbsp;Singh/Bloomberg)</p></div>
An employee removes vials of Covishield, the local name for the Covid-19 vaccine developed by AstraZeneca Plc at the Serum Institute of India Ltd. in Pune, Maharashtra, India. (Photographer: Dhiraj Singh/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More